Renovis, Inc. (RNVS)

CAPS Rating:

The Company is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases.

View Ticker Page (RNVS)

Results 1 - 7 of 7 : 1

Recs

2

Avatar drwings (< 20) Submitted: 10/24/06 4:04 PM : Start Price: $14.15 RNVS Score: -49.39

Stroke drug NXY-059, if it works, is likely to be $3 billion-a-year seller.

News on the drug, which was licensed in under a 15-percent royalty deal by Astro-zenica from Renovis is expected imminently because the last of more than 3,000 patients com...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar caps4brie (88.83) Submitted: 10/17/06 11:36 AM : Start Price: $14.08 RNVS Score: -50.46

company is under rated right now

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar tonzerone (39.70) Submitted: 10/26/06 1:16 PM : Start Price: $3.81 RNVS Score: -8.61

down 75% today, at cash value, will rebound

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar cramersaprentice (89.84) Submitted: 10/26/06 5:34 PM : Start Price: $3.51 RNVS Score: -4.03

this stock has been plastered and all the possible negitive news that is possible is out this one will move higher in the coming months

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar polvo23 (< 20) Submitted: 2/11/07 7:58 PM : Start Price: $3.54 RNVS Score: -2.16

turn around

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar maverickpl (99.86) Submitted: 4/10/07 1:17 PM : Start Price: $4.55 RNVS Score: -15.09

I really don't know much about biotech besides the whole thing is a crap shoot. I keep wanting to make underperform calls on these stocks because most of them fail. Having said that, perhaps one of them will go through the roof, and it really can't h...

Report this Post Replies: 0 | Reply | Permalink